Huwate Yeerna

1.7k total citations
15 papers, 762 citations indexed

About

Huwate Yeerna is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Huwate Yeerna has authored 15 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Huwate Yeerna's work include Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers) and Epigenetics and DNA Methylation (2 papers). Huwate Yeerna is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers) and Epigenetics and DNA Methylation (2 papers). Huwate Yeerna collaborates with scholars based in United States, Netherlands and Germany. Huwate Yeerna's co-authors include Pablo Tamayo, J. Silvio Gutkind, Victoria H. Wu, Razelle Kurzrock, Aaron M. Goodman, Asuka Inoue, Nijiro Nohata, Francesco Raimondi, Olivier Harismendy and Joshua Chiou and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Huwate Yeerna

15 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Huwate Yeerna United States	12	468	229	133	127	96	15	762
Irene Rodríguez‐Hernández Spain	15	481 1.0×	279 1.2×	191 1.4×	161 1.3×	93 1.0×	21	877
Jayasree S. Nair United States	15	419 0.9×	309 1.3×	206 1.5×	83 0.7×	98 1.0×	21	716
Mamunur Rashid United Kingdom	14	491 1.0×	248 1.1×	67 0.5×	220 1.7×	116 1.2×	19	817
Hanhua Huang United States	9	595 1.3×	182 0.8×	52 0.4×	262 2.1×	126 1.3×	14	869
Emily E. Bosco United States	12	654 1.4×	463 2.0×	229 1.7×	207 1.6×	97 1.0×	21	1.1k
Tom Truong United States	8	709 1.5×	393 1.7×	66 0.5×	231 1.8×	115 1.2×	12	1.0k
Ivanka Kovalyshyn United States	8	589 1.3×	588 2.6×	123 0.9×	186 1.5×	113 1.2×	16	1.0k
Barbie Taylor‐Harding United States	14	616 1.3×	420 1.8×	128 1.0×	177 1.4×	64 0.7×	16	936
Kah Suan Lim United States	10	538 1.1×	157 0.7×	59 0.4×	173 1.4×	60 0.6×	14	754
Lorenza Wyder Switzerland	11	850 1.8×	207 0.9×	219 1.6×	225 1.8×	114 1.2×	13	1.2k

Countries citing papers authored by Huwate Yeerna

Since Specialization

Citations

This map shows the geographic impact of Huwate Yeerna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huwate Yeerna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huwate Yeerna more than expected).

Fields of papers citing papers by Huwate Yeerna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huwate Yeerna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huwate Yeerna. The network helps show where Huwate Yeerna may publish in the future.

Co-authorship network of co-authors of Huwate Yeerna

This figure shows the co-authorship network connecting the top 25 collaborators of Huwate Yeerna. A scholar is included among the top collaborators of Huwate Yeerna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huwate Yeerna. Huwate Yeerna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Banerjee, Sudeep, Hyunho Yoon, Chih‐Min Tang, et al.. (2021). KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 20(10). 2035–2048. 10 indexed citations

Liu, Chao, Koji Ebisumoto, Akihiro Sakai, et al.. (2020). Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation. Clinical Cancer Research. 26(11). 2693–2703. 47 indexed citations

Panda, Anshuman, Anupama Yadav, Huwate Yeerna, et al.. (2020). Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Nucleic Acids Research. 48(13). 7079–7098. 19 indexed citations

Pham, Timothy V., Amélie Boichard, Aaron M. Goodman, et al.. (2020). Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy. Molecular Oncology. 14(8). 1680–1694. 39 indexed citations

Kim, Jong Wook, Christian Berrios, Mi‐Ju Kim, et al.. (2020). STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells. eLife. 9. 39 indexed citations

Wu, Xingyu, Huwate Yeerna, Yusuke Goto, et al.. (2019). Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells. Cancer Research. 79(17). 4360–4370. 43 indexed citations

Wu, Victoria H., Huwate Yeerna, Nijiro Nohata, et al.. (2019). Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. Journal of Biological Chemistry. 294(29). 11062–11086. 135 indexed citations

Feng, Xiaodong, Nadia Arang, Damiano Cosimo Rigiracciolo, et al.. (2019). A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. Cancer Cell. 35(3). 457–472.e5. 172 indexed citations

Tanaka, Tiffany, Dinh Diep, Huwate Yeerna, et al.. (2019). DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes. Blood Advances. 3(19). 2845–2858. 28 indexed citations

10.

Boichard, Amélie, Timothy V. Pham, Huwate Yeerna, et al.. (2018). APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy. OncoImmunology. 8(3). 1550341–1550341. 54 indexed citations

11.

Galanina, Natalie, Rafael Bejar, Michael Y. Choi, et al.. (2018). Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers. 11(1). 11–11. 44 indexed citations

12.

Srivas, Rohith, John Paul Shen, Su Ming Sun, et al.. (2016). A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. Molecular Cell. 63(3). 514–525. 98 indexed citations

13.

Shen, John Paul, Rohith Srivas, Ana Bojorquez-Gomez, et al.. (2015). Abstract 129: RAD17 loss of function is synthetically lethal with the checkpoint kinase inhibitors AZD7762 or MK-1775. Cancer Research. 75(15_Supplement). 129–129. 1 indexed citations

14.

Jumabay, Medet, et al.. (2015). Effect of Diabetes Mellitus on Adipocyte‐Derived Stem Cells in Rat. Journal of Cellular Physiology. 230(11). 2821–2828. 22 indexed citations

15.

Shen, John Paul, Rohith Srivas, Andrew M. Gross, et al.. (2015). Chemogenetic profiling identifiesRAD17as synthetically lethal with checkpoint kinase inhibition. Oncotarget. 6(34). 35755–35769. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact